Latest News
Schulte Roth & Zabel has added Peter Greene, Benjamin Kozinn, and Eileen Overbaugh as partners based in the firm’s New York office.
Greene is an industry leader who has advised many of the leading private fund launches over the past 17 years. He advises clients on all matters related to the formation and structuring of private funds and management companies, compliance and regulatory requirements, and public to private investment opportunities. He has particular experience in insider trading determinations, including the purchase, analysis, and use of alternative/big data and related enforcement.
He joins as a co-leader of the SRZ Investment
Yellow Wood Partners, a Boston-based private equity firm focused on investing in consumer brands and companies, has closed Yellow Wood Capital Partners III at its target and hard cap of USD750 million in limited partner capital commitments.
The new fund was oversubscribed and included capital commitments from many of Yellow Wood’s long-time limited partners as well as the addition of a small number of new investors comprised of university endowments, family offices and other institutional investors.
Yellow Wood Fund III continues its strategy of partnering with management teams to grow and operate brands by applying its Consumer Operating DNA
FirstPort, a UK residential property services company, is being acquired by Emeria, a European specialist in residential real estate services, from the company’s previous majority shareholder, the mid-market private equity investor Equistone Partners Europe Limited (Equistone).
FirstPort will operate as a subsidiary of Emeria, with its existing management team remaining in place and reinvesting in the group. The financial terms of the deal are undisclosed and completion of the transaction remains subject to approval by the Financial Conduct Authority.
FirstPort works with developers, investors, freeholders and over 1,300 Resident Management Companies (RMCs) to provide services to leaseholders.
Emeria is
Integra Therapeutics, a biotechnology company that creates next- generation gene writing tools, has closed an additional EUR1.5-million investment from venture capital firm Columbus Venture Partners. This investment comes on top of the EUR4.5 million Integra Therapeutics raised last December from AdBio Partners, Invivo Capital and Takeda Ventures and completes its seed round in line with the company’s set goals.
The new funds will go to support development of the FiCAT platform prototype and preclinical validation with in vivo and ex vivo models.
Charme Capital Partners (Charme), a pan-European mid-market private equity firm, and Amadeus Capital Partners (Amadeus), are to sell 100 per cent of Veritas Intercontinental to LetsGetChecked, a global healthcare solutions company.
LetsGetChecked, which is based in Dublin and New-York, the tools to manage health from home through direct access to diagnostic testing, virtual care, and medication delivery for a wide range of health and wellness conditions.
Veritas Intercontinental was founded in 2018 as a spin-off from Veritas Genetics and has led the activity and development of the Veritas brand outside of the United States, offering a wide range of genomic
Arowana Impact Capital (AIC), the impact investing arm of global B Corp investment group, Arowana, has completed a cornerstone investment in Green Antz, producer of eco-friendly construction materials operating in Southeast Asia.
Green Antz converts plastic waste from commercial establishments and communities into value-added construction materials, such as bricks and pavers. Green Antz does this through its network of EcoHubs across the Philippines, which serve as collection sites, production facilities, and recycling education centres.
This strategy enables Green Antz to tackle Asia’s burgeoning plastic waste problem, whilst offering cost-effective and environmentally responsible alternatives to traditional building materials.
Stanley Capital (SCP), a mid-market private equity firm focused on growing sustainable businesses in the Healthcare, Technology and Resource Efficiency sectors, and Applied Artificial Intelligence Corporation (AAICO), a artificial intelligence (AI) technology company headquartered in the UAE, are partnering to bring artificial intelligence to private equity investing.
The partnership will entail using AAICO’s proprietary AI technologies within Stanley Labs (‘S-Labs’), Stanley Capital’s technology arm, which focuses on developing and using AI and automation products to identify, evaluate and create value within SCP, its Healthcare Services and Software Special Purpose Acquisition Vehicle (‘SPAC’), and its portfolio companies.
AAICO and Stanley Capital
2022 will be the year the level of in-person and online meetings rebalance to create a new fundraising ‘normal’ for years to come…
The private market fundraising process underwent a historic transformation through the various stages of Covid-19, but many of the adjustments made during 2020 and 2021 are now being reviewed by GPs and LPs as travel restrictions and lockdowns ease in the UK, Europe and the US.
In 2020 fund managers relied mainly on existing relationships to raise and close funds virtually. Last year saw a shift back to engaging with new clients.
“In 2021, the situation largely
By Colin Leopold – Large institutional investors in Japan and South Korea are increasing their overseas private equity exposure but the process has been slow. A booming private wealth market could be quicker…
By Colin Leopold – Rising public market valuations and tech-based disruption has pushed investors towards sector specialist managers. Demand is now building for more general macro strategies too…
Special Reports
Featured
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
